These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 36343848)
21. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637 [TBL] [Abstract][Full Text] [Related]
22. Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis. Liu J; Weiss HL; Rychahou P; Jackson LN; Evers BM; Gao T Oncogene; 2009 Feb; 28(7):994-1004. PubMed ID: 19079341 [TBL] [Abstract][Full Text] [Related]
23. Biochemical characterization of the phosphatase domain of the tumor suppressor PH domain leucine-rich repeat protein phosphatase. Sierecki E; Newton AC Biochemistry; 2014 Jun; 53(24):3971-81. PubMed ID: 24892992 [TBL] [Abstract][Full Text] [Related]
24. Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase Acts as a Tumor Suppressor in Oral Squamous Cell Carcinoma. Etemad-Moghadam S; Mohammadpour H; Emami Razavi A; Alaeddini M Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):249-253. PubMed ID: 38602289 [TBL] [Abstract][Full Text] [Related]
25. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms. Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608 [TBL] [Abstract][Full Text] [Related]
27. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer. Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623 [TBL] [Abstract][Full Text] [Related]
28. Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output. Reyes G; Niederst M; Cohen-Katsenelson K; Stender JD; Kunkel MT; Chen M; Brognard J; Sierecki E; Gao T; Nowak DG; Trotman LC; Glass CK; Newton AC Proc Natl Acad Sci U S A; 2014 Sep; 111(38):E3957-65. PubMed ID: 25201979 [TBL] [Abstract][Full Text] [Related]
29. The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer. Li X; Stevens PD; Yang H; Gulhati P; Wang W; Evers BM; Gao T Oncogene; 2013 Jan; 32(4):471-8. PubMed ID: 22391563 [TBL] [Abstract][Full Text] [Related]
30. PHLPPs: Emerging players in metabolic disorders. Balamurugan K; Chandra K; Sai Latha S; Swathi M; Joshi MB; Misra P; Parsa KVL Drug Discov Today; 2022 Oct; 27(10):103317. PubMed ID: 35835313 [TBL] [Abstract][Full Text] [Related]
31. PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth. Liu J; Stevens PD; Li X; Schmidt MD; Gao T Mol Cell Biol; 2011 Dec; 31(24):4917-27. PubMed ID: 21986499 [TBL] [Abstract][Full Text] [Related]
32. PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases. Hribal ML; Mancuso E; Spiga R; Mannino GC; Fiorentino TV; Andreozzi F; Sesti G Expert Opin Ther Targets; 2016 Jun; 20(6):663-75. PubMed ID: 26652182 [TBL] [Abstract][Full Text] [Related]
33. Emerging roles of PHLPP phosphatases in metabolism. Cha JH; Jeong Y; Oh AR; Lee SB; Hong SS; Kim K BMB Rep; 2021 Sep; 54(9):451-457. PubMed ID: 34353431 [TBL] [Abstract][Full Text] [Related]
34. Detection of PHLPP1α/β in human and mouse brain by different anti-PHLPP1 antibodies. Jackson TC; Bayir H; Ikonomovic MD; Janesko-Feldman K; Mi Z; Gao T; Jackson EK; Kochanek PM Sci Rep; 2015 Apr; 5():9377. PubMed ID: 25827478 [TBL] [Abstract][Full Text] [Related]
35. Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells. Patterson SJ; Han JM; Garcia R; Assi K; Gao T; O'Neill A; Newton AC; Levings MK J Immunol; 2011 May; 186(10):5533-7. PubMed ID: 21498666 [TBL] [Abstract][Full Text] [Related]
36. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation. Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669 [TBL] [Abstract][Full Text] [Related]
37. Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation. Bradley EW; Carpio LR; Newton AC; Westendorf JJ J Biol Chem; 2015 Jun; 290(26):16272-80. PubMed ID: 25953896 [TBL] [Abstract][Full Text] [Related]
38. High PHLPP expression is associated with better prognosis in patients with resected lung adenocarcinoma. Lv D; Yang H; Wang W; Xie Y; Hu W; Ye M; Chen X BMC Cancer; 2015 Oct; 15():687. PubMed ID: 26463718 [TBL] [Abstract][Full Text] [Related]